Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma. Laschinsky C, Theurer S, Herold T, Rawitzer J, et al. J Nucl Med 2023 Oct 26:jnumed.123.266044. doi: 10.2967/jnumed.123.266044.

Read + Share

Amedeo Smart

Independent Medical Education

Laschinsky C, Theurer S, Herold T, Rawitzer J, et al. Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma. J Nucl Med 2023 Oct 26:jnumed.123.266044. doi: 10.2967/jnumed.123.266044.
PMID: 37884333